Diseases, Conditions, Syndromes

COVID-19 fattens up our body's cells to fuel its viral takeover

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

Medications

Psilocybin use associated with lower risk of opioid addiction

Adults who have at some time in their life used psilocybin—a psychedelic substance produced by some types of mushrooms—are 30% less likely to have opioid use disorder, according to a nationally representative survey of ...

Diseases, Conditions, Syndromes

Compendium on rapid tests for COVID-19 offers insights

A clinical practice article in the New England Journal of Medicine distills available data and clinical experience into a compendium about rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The appendix ...

Oncology & Cancer

Tackling tumors with two types of virus

An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in experiments ...

Diseases, Conditions, Syndromes

How a lung injury study helped inspire new COVID-19 drug trials

When Anna Greka, an institute member at the Broad Institute of MIT and Harvard and a physician at Brigham and Women's Hospital, volunteered to help care for patients with COVID-19 at the peak of Boston's springtime surge, ...

Medical research

Using Epo to treat COVID-19

Erythropoietin (Epo) is actually a medication for anemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth ...

page 2 from 14